|
Chen, A Y; Liu, L F (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218
|
|
Tsao, Y P; Russo, A; Nyamuswa, G et al. (1993) Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res 53:5908-14
|
|
Woessner, R D; Eng, W K; Hofmann, G A et al. (1992) Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. Oncol Res 4:481-8
|
|
Mattern, M R; Hofmann, G A; McCabe, F L et al. (1991) Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Res 51:5813-6
|
|
Mattern, M R; Nambi, P; Bartus, J O et al. (1991) Regulation of topoisomerase I and II activities by cyclic nucleotide- and phospholipid-dependent protein kinases. Effects of interactions between the two transduction pathways. Receptor 1:181-90
|
|
Woessner, R D; Mattern, M R; Mirabelli, C K et al. (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209-14
|
|
Kingsbury, W D; Boehm, J C; Jakas, D R et al. (1991) Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem 34:98-107
|
|
Hofmann, G A; Mirabelli, C K; Drake, F H (1990) Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II. Anticancer Drug Des 5:273-82
|
|
Mattern, M R; Mong, S; Mong, S M et al. (1990) Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells. Biochem J 265:101-7
|
|
Eng, W K; McCabe, F L; Tan, K B et al. (1990) Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Mol Pharmacol 38:471-80
|
Showing the most recent 10 out of 41 publications
